Loading...
Many infants with symptoms that suggest gastroesophageal reflux (GER) receive acid-reducing medications, despite questions about their necessity and efficacy. To assess the benefit of nonpharmacologic interventions, investigators used the validated Infant Gastroesophageal Reflux Questionnaire-Revised (I-GERQ-R) to compare GER symptoms in 37 infants (age range, 4–43 weeks) at baseline and 2 weeks after their parents were taught conservative treatment measures. Infants at five U.S. outpatient pediatric sites were included in the study if they had a minimum I-GERQ-R score consistent with GER disease (score >16 out of 42).
Conservative measures consisted of using hypoallergenic formula, thickening formula with dry rice cereal, eliminating cow’s …